Fig. 4
From: Targeting HER2-breast tumors with scFv-decorated bimodal nanoprobes
Quantitative evaluation of HER2 proteins on breast cancer cell lines. Flow cytometry data giving the percentage of positive cells (a) and the mean fluorescence intensity (MFI) (b) on SK-BR3, BT-474, MDA-MB231 and MCF-7 breast cancer cells. (c) Uptake of scFv-nanoprobes by BT-474, MDA-MB231 and MCF-7 cells according time from 15 to 360 min